Clinical pharmacy services in hematology can have a significant impact, and the Pharmacy Times® Hematology resource center provides clinical news and articles about the topic. Here, visitors will find information about upcoming hematology conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
Trending News Today: Acute Myeloid Leukemia Drug Improves Overall Survival
Top news of the day from across the health care landscape.
The Oncology Pharmacist's Blind Spot
Hematology and oncology pharmacists discussed patient outreach at a panel during the Hematology/Oncology Pharmacy Association’s (HOPA) annual conference in April.
New Approach May Overcome Drug Resistance in Acute Myeloid Leukemia
A new study identified pathways that may serve as therapeutic targets for overcoming drug resistance in acute myeloid leukemia. 
Combating Advancing Cancers With CAR T-Cell Therapy
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
DAURISMO for Acute Myeloid Leukemia
On November 2018, the FDA approved Pfizer’s glasdegib (Daurismo) for the treatment of newly diagnosed acute myeloid leukemia (AML) in patients 75 years and older with comorbidities that prevent the use of intensive induction-dose chemotherapy.
Melanoma Associated with CLL Creates Need for Closer Monitoring
The study findings suggest that, while the link between chronic lymphocytic leukemia and melanoma had been known, the rate at which the link occurs is higher than expected.
Rituximab Biosimilar Candidate Shows Clinical Equivalence in Non-Hodgkin Lymphoma
ABP 798, a biosimilar candidate to rituximab (Rituxan), demonstrated clinical equivalence in a study of patients with non-Hodgkin lymphoma.
Drug Combination Leads to Effective Response, Remission in Patients with Multiple Myeloma
Selinexor with dexamethasone effective in more than one-quarter of patients with multiple myeloma during a clinical trial.
Trending News Today: Multiple Myeloma Drug Achieves Clinically Meaningful Response Rate
Top news of the day from across the health care landscape.
Drug Regimen Found More Effective Than Chemoimmunotherapy for Patients With CLL
Combination of ibrutinib and rituximab found to improve overall survival in patients with chronic lymphocytic leukemia.
FDA Grants Priority Review to Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma
Zanubrutinib, a Bruton’s tyrosine kinase inhibitor, is being evaluated in a broad pivotal clinical program across multiple B-cell malignancies.
Risk of MGUS, Multiple Myeloma Progression May Change Over Time
Research highlights the importance of regular blood testing to impove earlier detection of multiple myeloma.
+ Load More